Hiva Kolodrubetz, NP, provides an engaging and detailed session on anti-diabetic medications, focusing on safe prescribing and effective management strategies. Highlighting pharmacological mechanisms, A1C goals, and patient-centered care,…
Associate Professor Mike Todorovic, AKA “Dr. Mike”, introduces the endocrine system, explaining how hormones act as chemical messengers released into the bloodstream by cells, tissues, and glands. He…
NEW YORK (Reuters Health) – A 2.5-mg dose of terbutaline at bedtime appears to prevent hypoglycemia during the night in patients with aggressively treated type 1 diabetes, without…
NEW YORK (Reuters Health) – Long-term treatment with fenofibrate does not seem to reduce atherosclerosis, inflammation or endothelial dysfunction in patients with type 2 diabetes, according to a…
NEW YORK (Reuters Health) – In a prospective study of adult patients at Massachusetts General Hospital in Boston, nearly one in five had elevated glycosylated hemoglobin A (HbA1c)…
NEW YORK (Reuters Health) – Women younger than 65 with diabetes tend to have worse cardiovascular risk profiles than diabetic men of the same age, leading to higher…
NEW YORK (Reuters Health) – New research shows that among the cognitive abilities that are affected by type 2 diabetes, processing speed appears to be the most severely…
NEW YORK (Reuters Health) – In a randomized, controlled long-term study of children with idiopathic short stature who were not growth hormone (GH) deficient, GH treatment, started as…
NEW YORK (Reuters Health) – In patients with unstable type 1 diabetes, hypoglycemia awareness — which often deteriorates over time — can be enhanced with islet transplantation, new…
Dr. Armand Daccache, Associate Director of the Residency Program and Assistant Professor of the Retina / Vitreous Section at the Yale Eye Center, discusses the use of focal…
NEW YORK (Reuters Health) – Routine periodic fasting is associated with reduced incidence of coronary artery disease (CAD) and diabetes, according to findings from the Intermountain Heart Collaborative…
NEW YORK (Reuters Health) – Hypogonadotrophic hypogonadism is present in about a third of men between the ages of 18 to 35 who have type 2 diabetes, researchers…
